Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$70,761,506
-$7,906,171 QoQ
Shares Held
195,409
-12.6% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#183
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 69%
None 31%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $4,379,567,692 across 14 Drug Manufacturers - General names. AMGN ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,190,792 | $1,428,271,766 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,484,756 | $833,291,145 | |
| 3 | JNJ |
Johnson & Johnson
|
3,255,567 | $826,816,350 | |
| 4 | ABBV |
AbbVie Inc.
|
2,374,888 | $597,616,815 | |
| 5 | AZN |
Astrazeneca PLC
|
1,233,595 | $233,914,282 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,845,511 | $233,161,858 | |
| 7 | AMGN |
Amgen Inc
This page
|
195,409 | $70,761,506 | |
| 8 | BIIB |
Biogen Inc.
|
246,782 | $53,319,718 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,761,506 | 195,409 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $78,667,677 | 223,583 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $70,456,095 | 215,258 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $55,955,744 | 198,284 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $132,256,750 | 473,682 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $179,446,568 | 575,980 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $115,255,789 | 442,203 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $387,714,647 | 1,203,298 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $312,216,598 | 999,253 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $106,469,878 | 374,472 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $139,463,027 | 484,213 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $121,774,349 | 453,097 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $82,337,891 | 370,858 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $89,785,949 | 371,400 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $137,818,763 | 524,744 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $97,857,184 | 434,149 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $74,835,915 | 307,587 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $80,546,855 | 333,086 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $77,762,679 | 345,658 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $63,491,335 | 298,572 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $74,400,300 | 305,232 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $81,448,202 | 327,351 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $80,479,127 | 350,031 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $102,928,191 | 404,974 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $99,544,712 | 422,050 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $98,190,246 | 484,340 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||